Stem cell immunology

Advances in Tissue Engineering

Volumn , Issue , 2008, Pages 199-213

  Hollander, Anthony P ^a   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adult Stem Cells; Embryonic Stem Cells; Immune Privilege; Immune Rejection; Immune Suppression

Indexed keywords

EID: 84967630955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781848161832_0010     Document Type: Chapter

References (39)

1. Lechler, R.I., Sykes, M., Thomson, A.W. and Turka, L.A. Organ transplantation - how much of the promise has been realized? Nat. Med. 11(6), 605-613 (2005).
2. Lechler, R. and George, A.J.T. Transplantation and rejection. In: Male, D., Brostoff, J., Roth, D.B. and Roitt, I. (eds.), Immunology (Mosby/Elsevier, Philadelphia, 2006), pp. 383-400.
3. Drukker, M. and Benvenisty, N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22(3), 136-141 (2004).
4. Mayhall, E.A., Paffett-Lugassy, N. and Zon, L.I. The clinical potential of stem cells. Curr. Opin. Cell. Biol. 16(6), 713-720 (2004).
5. Male, D. Introduction to the immune system. In: Male, D., Brostoff, J., Roth, D.B. and Roitt, I. (eds.), Immunology (Mosby/Elsevier, Philadelphia, 2006), pp. 3-18.
6. Platts-Mills, T.A.E., Male, D., Hay, F., Westwood, O.M.R. and Britton, W. Hypersensitivity in immunology. In: Male, D., Brostoff, J., Roth, D.B. and Roitt, I. (eds.), Immunology (Mosby/Elsevier, Philadelphia, 2006), pp. 423-492.
7. Du Pasquier, L. Meeting the demand for innate and adaptive immunities during evolution. Scand J. Immunol. 62(Suppl. 1), 39-48 (2005).
8. Pancer, Z. and Cooper, M.D. The evolution of adaptive immunity. Annu. Rev. Immunol. 24, 497-518 (2006).
9. Pancer, Z., Amemiya, C.T., Ehrhardt, G.R., Ceitlin, J., Gartland, G.L. and Cooper, M.D. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430(6996), 174-180 (2004).
10. Jefferis, R. Antibodies in immunology. In: Male, D., Brostoff, J., Roth, D.B. and Roitt, I. (eds.), Immunology (Mosby/Elsevier; Philadelphia, 2006), pp. 59-86.
11. Roth, D.B. T cell receptors and MHC molecules. In: Male, D., Brostoff, J., Roth, D.B. and Roitt, I. (eds.), Immunology (Mosby/Elsevier, Philadelphia, 2006), pp. 105-126.
12. Fandrich, F., Dresske, B., Bader, M. and Schulze, M. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J. Mol. Med. 80(6), 343-350 (2002).
13. Barry, F.P., Murphy, J.M., English, K. and Mahon, B.P. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev. 14(3), 252-265 (2005).
14. Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz- Eldor, J. et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99(15), 9864-9869 (2002).
15. Drukker, M. Immunogenicity of human embryonic stem cells: can we achieve tolerance? Springer Semin. Immunopathol. 26(1-2), 201-213 (2004).
16. Burt, R.K., Verda, L., Kim, D.A., Oyama, Y., Luo, K. and Link, C. embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J. Exp. Med. 199(7), 895-904 (2004).
17. Li, L., Baroja, M.L., Majumdar, A., Chadwick, K., Rouleau, A., Gallacher, L. et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22(4), 448-456 (2004).
18. Grinnemo, K.H., Sylven, C., Hovatta, O., Dellgren, G. and Corbascio, M. Immunogenicity of human embryonic stem cells. Cell Tissue Res. 331, 67-78 (2008).
19. Fairchild, P.J., Robertson, N.J., Minger, S.L. and Waldmann, H. Embryonic stem cells: protecting pluripotency from alloreactivity. Curr. Opin. Immunol. 19, 596-602 (2007).
20. Menard, C., Hagege, A.A., Agbulut, O., Barro, M., Morichetti, M.C., Brasselet. C. et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366(9490), 1005-1012 (2005).
21. Hildebrand, M.S., Dahl, H.H., Hardman, J., Coleman, B., Shepherd, R.K. and de Silva, M.G. Survival of partially differentiated mouse embryonic stem cells in the scala media of the guinea pig cochlea. J. Assoc. Res. Otolaryngol. 6(4), 341-354 (2005).
22. Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E. et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24(2), 221-229 (2006).
23. Bonnevie, L., Bel, A., Sabbah, L., Al Attar, N., Pradeau, P., Weill, B. et al. Is xenotransplantation of embryonic stem cells a realistic option? Transplantation 83(3), 333-335 (2007).
24. Kofidis, T., deBruin, J.L., Tanaka, M., Zwierzchoniewska, M., Weissman, I., Fedoseyeva, E. et al. They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur. J. Cardiothorac. Surg. 28(3), 461-466 (2005).
25. Taylor, C.J., Bolton, E.M., Pocock, S., Sharples, L.D., Pedersen, R.A. and Bradley, J.A. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366, 2019-2025 (2005).
26. Liechty, K.W., MacKenzie, T.C., Shaaban, A.F., Radu, A., Moseley, A.M., Deans, R. et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6(11), 1282-1286 (2000).
27. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E. and Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31(10), 890-896 (2003).
28. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5(6), 485-489 (2003).
29. Ilancheran, S., Michalska, A., Peh, G., Wallace, E.M., Pera, M. and Manuelpillai, U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol. Reprod. 77(3), 577-588 (2007).
30. Aggarwal, S. and Pittenger, MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4), 1815-1822 (2005).
31. Dazzi, F., Ramasamy, R., Glennie, S., Jones, S.P. and Roberts, I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 20(3), 161-171 (2006).
32. Liu, H., Kemeny, D.M., Heng, B.C., Ouyang, H.W., Melendez, A.J. and Cao, T. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J. Immunol. 176(5), 2864-2871 (2006).
33. Chen, X., McClurg, A., Zhou, G.Q., McCaigue, M., Armstrong, M.A. and Li, G. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells 25(2), 364-370 (2007).
34. Le Blanc, K. and Pittenger, M. Mesenchymal stem cells: progress toward promise. Cytotherapy 7(1), 36-45 (2005).
35. Le Blanc, K. Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8(6), 559-561 (2006).
36. Fibbe, W.E., Nauta, A.J. and Roelofs, H. Modulation of immune responses by mesenchymal stem cells. Ann. N. Y. Acad. Sci. 1106, 272-278 (2007).
37. van Laar, J.M. and Tyndall, A. Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 45(10), 1187-1193 (2006).
38. Uccelli, A., Moretta, L. and Pistoia, V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 36, 2566-2573 (2006).
39. Koch, C.A., Geraldes, P. and Platt, J.L. Immunosuppression by embryonic stem cells. Stem Cells 26, 89-98 (2008).